ENDOMETRIOSIS FOUNDATION OF AMERICA INC
Balance Sheet
Fiscal Year Start:
Jan 1
Assets in 2024 (Year End)
$2,836,213
Investments
73%
Cash & Equivalents
18%
Receivables (Non-Related)
7%
Prepaid Expenses
2%
Property, Plant, & Equipment (net)
<1%
Related-Party Receivables
0%
Inventories
0%
Other Assets
0%
Liabilities in 2024 (Year End)
$63,476
Payables & Accruals
>99%
Grants Payable
0%
Deferred Revenue
0%
Tax-Exempt Bond Liabilities
0%
Custodial & Escrow Liabilities
0%
Notes Payable / Debt (Non-Related)
0%
Related-Party Payables
0%
Other Liabilities
0%
Assets
2023
2024
Change
Cash & Equivalents
$1,038,107
$504,246
-51%
Receivables (Non-Related)
$416,130
$204,188
-51%
Related-Party Receivables
-
-
-
Inventories
-
-
-
Prepaid Expenses
$49,229
$46,790
-5%
Investments
$1,166,484
$2,078,382
+78%
Property, Plant, & Equipment (net)
$1,940
$2,607
+34%
Other Assets
-
-
-
Total Assets
$2,671,890
$2,836,213
+6%
Liabilities
2023
2024
Change
Payables & Accruals
$94,311
$63,476
-33%
Grants Payable
-
-
-
Deferred Revenue
-
-
-
Tax-Exempt Bond Liabilities
-
-
-
Custodial & Escrow Liabilities
-
-
-
Notes Payable / Debt (Non-Related)
-
-
-
Related-Party Payables
-
-
-
Other Liabilities
-
-
-
Total Liabilities
$94,311
$63,476
-33%
Net assets
2023
2024
Change
Restricted Net Assets
$745,434
$745,434
+0%
Unrestricted Net Assets
$1,832,145
$2,027,303
+11%
Net assets
2023
2024
Change
Net assets
+$2,577,579
+$2,772,737
+8%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)